Safety of a Single Dose or Two Doses of Shenzhen Quadrivalent Influenza Vaccine
Clinical trial NCT03430089 · COMPLETED
Trial details
- NCT number
- NCT03430089
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-22
- Primary completion
- 2019-06-06
- Enrollment
- 101
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.